FLI-100 FIA Analyzer

FLI-100 FIA Analyzer

Services and Business Facilitation

Information

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.
Xiamen Biotime Biotechnology Co.,ltdH6.B52Established in April 2008, Biotime Biotechnology, situated in the Xiamen Special Economic Zone, is an innovative healthcare manufacturer dedicated to promoting global health through diagnostic solutions. With a worldwide customer base, Biotime delivers exceptional medical devices and diagnostics. Holding over 50 patents, the company remains devoted to technological innovation, offering in vitro diagnostic solutions that utilize a variety of technologies. Biotime's significant investment in R&D underlines its commitment to progress. Its team of doctoral researchers collaborate with esteemed institutions, advancing the fields of rapid diagnostics and POCT technology. Biotime's proficient management team, bringing together diverse expertise and vast experience, ensures the company's success and maintains its accountability within the industry.

Log in